We previously demonstrated that proglumide treatment prevents the release of cancer-derived neutrophil elastase-rich exosomes in the TME (abstract, APS April 2025), thus providing an explanation for the changes noted in this investigation with fewer M2-polarized TAMs in tumors of proglumide-treated mice. The gene discussed is ELANE; the disease is cancer.